VIR Funding: How Much Did They Raise & Key Investors

How Much Did VIR Raise?
Funding & Key Investors

Vir Biotechnology has solidified its position as a leader in the immunology sector, securing a total capital infusion of $260M. This financial trajectory is underscored by a recent strategic investment of $10M, which serves to bolster the company's ongoing research and development initiatives. By leveraging significant backing from global health organizations and pharmaceutical giants, Vir continues to advance its mission of addressing high-unmet medical needs through sophisticated immune-system modulation.

The company's funding history reflects a deliberate growth strategy, moving from foundational support to major enterprise-level financing. This capital allocation is critical for sustaining the long-term clinical trials and technological infrastructure required to bring complex antibody-based therapies to market.

What is VIR?

VIR

Business Services

Research & Development

Vir Biotechnology operates at the intersection of advanced immunology and infectious disease research. The firm specializes in developing innovative therapies that harness the human immune system to treat and prevent serious, often chronic, conditions. Its core research focus encompasses antibody-based medicines and immune technologies targeting hepatitis delta, hepatitis B, HIV, and various oncological applications. By integrating deep scientific expertise with a robust clinical pipeline, Vir is positioned as a pivotal player in the global biotechnology landscape, aiming to transform the standard of care for patients suffering from complex, high-burden diseases.

How much funding has VIR raised?

VIR has raised a total of $260M across 2 funding rounds:

2020

Unspecified

$250M

2023

Grant

$10M

Unspecified (2020): $250M with participation from GlaxoSmithKline

Grant (2023): $10M led by Bill & Melinda Gates Foundation

Key Investors in VIR

GlaxoSmithKline

GSK is a global pharmaceutical leader focused on the research and development of medicines and vaccines across respiratory, immunology, oncology, and infectious disease therapeutic areas.

Bill & Melinda Gates Foundation

A prominent philanthropic organization dedicated to improving global health outcomes and supporting individuals experiencing extreme poverty through strategic investments in medical research.

What's next for VIR?

With the recent influx of capital, Vir Biotechnology is well-positioned to accelerate its clinical development programs and expand its therapeutic reach. The strategic focus will likely remain on optimizing its antibody-based platform to address persistent infectious diseases and emerging immunological challenges. As the company matures, the emphasis will shift toward scaling its manufacturing capabilities and navigating the regulatory pathways for its late-stage candidates. Investors and industry observers will be monitoring the company's ability to translate its scientific breakthroughs into commercialized, life-saving treatments, thereby solidifying its market share in the competitive biopharmaceutical sector.

See full VIR company page

See More Financial Insights

No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Automated Meter Solutions

Advertising Networks

Business Services

eventaces

Business Services

Human Resources Management Systems (HRMS)

Revolution Catering

Business Services

Food Service

Publicide

Business Services

Commercial Printing

Frequently Asked Questions Regarding VIR Financial Insights

What are the most recent funding rounds that VIR has completed, and what were the funding rounds?

VIR has recently completed 2 funding rounds: Grant on May 4, 2023, Unspecified on Apr 7, 2020.

What is the total amount of funding VIR has raised to date?

VIR has raised a total of $260M in funding to date.

How many funding rounds has VIR completed?

VIR has completed 2 funding rounds.

How much funding did VIR raise in its most recent funding round?

VIR raised $10M in its most recent funding round.

Who are the lead investors in VIR's latest funding round?

The lead investor in VIR's latest funding round was Bill & Melinda Gates Foundation. To access investor data and explore similar companies, sign up for ZoomInfo.

Which was the largest funding round in VIR's history?

The largest funding round in VIR's history was $250M.

See more information about VIR